Horizon Pharma plc - Company & Market Research Reports

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

From
From
From
From
From
From
From
Chronic Back Pain - Pipeline Insight, 2018 - Product Thumbnail Image

Chronic Back Pain - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
From
From
From
Liver Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H2 2016

  • Drug Pipelines
  • 1171 Pages
From
From
Loading Indicator
adroll